71 /100
HIGH RISK
Score updated Apr 28, 2026

CTOR

Citius Oncology, Inc. — Stock Dilution Tracker

Track CTOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track CTOR — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
75
⚠️ Warrant Exposure
15
🔄Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split 70%
• 50-day avg $0.86 below $1 exchange minimum
• Only 4 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (71/100)
🔔 Track CTOR — Get forecast alerts →
💹 Market Data
Market Cap$76.53M
Shares Outstanding88.28M
Float14.13M
Cash$7.30M
Debt$3.80M
Short InterestN/A
🏛 Institutional Holdings
7.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track CTOR for full holder detail →
📉 Short Interest
Short Interest934.9K
Days to Cover5.6
% of Float6.6%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Jul 17, 2025
EFFECT EFFECT Mar 02, 2026
EFFECT EFFECT Jan 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
Track CTOR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTOR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: AURX BCTX CDT CHRS COOT
🔬 More Research for CTOR
📊 CTOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CTOR Signal Convergence & Dark Pool Activity — StonkWhisper 📄 CTOR Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.